The global Circulating Tumor Cells (CTCs) market was USD 9.7 billion in 2022 and is expected to register a revenue CAGR of 11.5% during the forecast period. Advancements in the field of liquid biopsy and increased cancer incidence are major factors driving market revenue growth.
https://www.reportsanddata.com..../report-detail/circu